Bethany Sensenig, Director: Supernus Pharmaceuticals SUPN Sell · Filed 02/23

Trade details

Type: Insider sale
Amount: $167,037.66
Shares · price: 3,258 sh · $51.27 a share
Held after: 0 sh
Stock: Supernus Pharmaceuticals SUPN
Person: Bethany SensenigDirector
Trade date: 26/02/19
Filed: 26/02/23
Days to filing: 4 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Supernus Pharmaceuticals trades, last 26 weeks

What else happened in Supernus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/20~03/21

Bethany Sensenig's recent trades

Bethany SensenigDirector
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$61.2K
1,217 sh
$61.2K
Filed 02/23
Traded 02/19
Bethany SensenigDirector
Planned sale10b5-1 planSupernus Pharmaceuticals
Planned sale10b5-1 plan
Supernus Pharmaceuticals
SUPN
$224.6K
4,475 sh
$224.6K
Filed 02/19
Traded 02/19
Bethany SensenigDirector
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$226.8K
5,369 sh
$226.8K
Filed 25/08/18
Traded 25/08/14
Bethany SensenigDirector
Planned sale10b5-1 planSupernus Pharmaceuticals
Planned sale10b5-1 plan
Supernus Pharmaceuticals
SUPN
$228.9K
5,369 sh
$228.9K
Filed 25/08/14
Traded 25/08/14
Bethany SensenigCFO
Sell9 Meters Biopharma
Sell
9 Meters Biopharma
NMTR
$11K
9,100 sh
$11K
Filed 23/04/21
Traded 23/04/21

Bethany Sensenig, Director — sold $167K of Supernus Pharmaceuticals SUPN · 100.0% of holdings · 10b5-1 plan | Whalegun